Aptabio has ranked among the top searched stocks on 6 days in the past month.


As of 11:30 AM on the 11th, Aptabio is trading at 69,300 KRW, down 1.56% from the previous day. This represents an 84.8% increase compared to December 11th.

Over the past 5 days, individual investors have net purchased 396,826 shares, while foreigners and institutions have net sold 111,818 shares and 263,691 shares, respectively.


On January 6th, Aptabio became a market issue with the headline "Surge due to COVID-19 treatment FDA Phase 2 clinical trial application."



※Source: AI investment assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing